Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
1.
J Control Release ; 223: 207-214, 2016 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-26686081

RESUMO

The treatment of various hair disorders has become a central focus of good dermatologic patient care as it affects men and women all over the world. For many inflammatory-based scalp diseases, glucocorticoids are an essential part of treatment, even though they are known to cause systemic as well as local adverse effects when applied topically. Therefore, efficient targeting and avoidance of these side effects are of utmost importance. Optimizing the balance between drug release, interfollicular permeation, and follicular uptake may allow minimizing these adverse events and simultaneously improve drug delivery, given that one succeeds in targeting a sustained release formulation to the hair follicle. To test this hypothesis, three types of polymeric nanocarriers (nanospheres, nanocapsules, lipid-core nanocapsules) for the potent glucocorticoid clobetasol propionate (CP) were prepared. They all exhibited a sustained release of drug, as was desired. The particles were formulated as a dispersion and hydrogel and (partially) labeled with Rhodamin B for quantification purposes. Follicular uptake was investigated using the Differential Stripping method and was found highest for nanocapsules in dispersion after application of massage. Moreover, the active ingredient (CP) as well as the nanocarrier (Rhodamin B labeled polymer) recovered in the hair follicle were measured simultaneously, revealing an equivalent uptake of both. In contrast, only negligible amounts of CP could be detected in the hair follicle when applied as free drug in solution or hydrogel, regardless of any massage. Skin permeation experiments using heat-separated human epidermis mounted in Franz Diffusion cells revealed equivalent reduced transdermal permeability for all nanocarriers in comparison to application of the free drug. Combining these results, nanocapsules formulated as an aqueous dispersion and applied by massage appeare to be a good candidate to maximize follicular targeting and minimize drug penetration into the interfollicular epidermis. We conclude that such nanotechnology-based formulations provide a viable strategy for more efficient drug delivery to the hair follicle. Moreover, they present a way to minimize adverse effects of potent glucocorticoids by releasing the drug in a controlled manner and simultaneously decreasing interfollicular permeation, offering an advantage over conventional formulations for inflammatory-based skin/scalp diseases.


Assuntos
Anti-Inflamatórios/administração & dosagem , Clobetasol/administração & dosagem , Folículo Piloso/metabolismo , Nanocápsulas/administração & dosagem , Animais , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacocinética , Clobetasol/química , Clobetasol/farmacocinética , Liberação Controlada de Fármacos , Humanos , Hidrogéis , Estimulação Física , Poliésteres/química , Suínos
2.
Mini Rev Med Chem ; 12(6): 534-50, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22587767

RESUMO

During the last decade the technological advances in drug discovery changed the absorption, distribution, metabolism, excretion and toxicity (ADMET) profiles of New Chemical Entities (NCEs). Among ADMET processes, absorption plays an important role in the research and development of more effective orally administered drugs. Although significant progress has been made in in vitro, in situ and in vivo experimental determinations of absorption, the development of in silico methodologies has emerged as a cheaper and fast alternative to predict them. Even though several in silico models have been described in the literature to predict oral bioavailability and related properties, the prediction accuracy and their potential use is still limited. The low precision and high variability of data, the lack of a complete experimental and theoretical validation of in silico approach, and above all, the multi-factorial nature of the oral absorption term, make the development of predictive in silico models a thorny task. The present review discusses several important advances regarding the QSPR approaches used in the development of predictive oral bioavailability models. The importance of fixing the problem associated with data resource, as well as improving the reliability of in silico results is highlighted. Optimization of individual properties along the absorption process must be integrated in a multi-objective scenario for studying oral bioavailability behavior in the early drug discovery and development.


Assuntos
Disponibilidade Biológica , Relação Quantitativa Estrutura-Atividade , Administração Oral
3.
Ars pharm ; 51(4): 169-176, oct.-dic. 2010.
Artigo em Inglês | IBECS | ID: ibc-88502

RESUMO

Currently there are several cases in the field of the European Union regarding Spanishlegislation on private pharmacy planning. The first of these cases was initiated by issuing areasoned opinion by the European Commission on 28 June 2006. The second approach hastaken place through the various preliminary questions raised before the Court of Justice ofthe European Communities by certain Spanish courts. Although not all of the aboveprocedures have been completed, certain European pronouncements do provide what mightbe the consequences that they may have on the Spanish legislation on the subject. It is verylikely that the binomial property-ownership in favor of pharmacists and planning criteriaestablished in the Spanish regulations is considered compatible with European law. On thecontrary, it is feasible that certain aspects of the merit scales applied by the AutonomousCommunities for awarding newly authorized community pharmacies must be changed(AU)


Assuntos
Humanos , Assistência Farmacêutica/legislação & jurisprudência , Legislação Farmacêutica/tendências , Indústria Farmacêutica/legislação & jurisprudência , União Europeia
4.
Ars pharm ; 50(3): 144-152, jul.-sept. 2009.
Artigo em Inglês | IBECS | ID: ibc-77752

RESUMO

This article studies the differences between the models of candidate classification for the adjudication of new pharmacies in the different Spanish self-governing regions. The objective of this study is to analyze the profile of the selected professional. Generally, the ranking takes into account the professional activity as pharmacist, the pre-graduate formation as well as the postgraduate, with different weights. Some of the 15 autonomies include as merits the cooficial languages, an optional written test and special situations as unemployment.In general, the criteria try to find out the best profile of pharmacist based on the professional experience and the postgraduate formation(AU)


Assuntos
Humanos , Farmácias/legislação & jurisprudência , Licenciamento em Farmácia/normas , Farmácias , Farmácias/provisão & distribuição , Acreditação de Instituições de Saúde
5.
Int J Pharm ; 378(1-2): 101-7, 2009 Aug 13.
Artigo em Inglês | MEDLINE | ID: mdl-19501148

RESUMO

The objective of this work was to develop a simple and inexpensive transdermal formulation containing Nortriptyline Hydrochloride (NTH) for smoking cessation support therapy. Hydroxypropyl-methyl-cellulose was chosen as polymer and a mixture of transdermal enhancers (selected from previous research) was incorporated. The formulations were characterised in terms of appearance, thickness, uniformity of NTH content, release and skin permeation. Release studies demonstrated controlled release for four formulations. Diffusion studies were performed through human heat separated epidermis (HHSE) using Franz Diffusion Cells (FDC). Patches provided different fluxes varying from 20.39+/-7.09 microg/(cm(2) h) to 256.19+/-94.62 microg/(cm(2) h). The penetration profiles of NTH within the stratum corneum (SC) and deeper skin layers (DSL) were established after three administration periods (3 h, 6 h, and 24 h). Skin changes induced by the application of the patches were observed by confocal laser scanning microscopy (CLSM). The highest flux obtained would provide the recommended doses for smoke cessation support therapy (25-75 mg per day) with a 2 cm x 2 cm patch or a 3.5 cm x 3.5 cm patch, respectively, without skin damage evidence.


Assuntos
Inibidores da Captação Adrenérgica/farmacocinética , Nortriptilina/farmacocinética , Absorção Cutânea , Abandono do Hábito de Fumar/métodos , Administração Cutânea , Inibidores da Captação Adrenérgica/administração & dosagem , Inibidores da Captação Adrenérgica/toxicidade , Química Farmacêutica/métodos , Excipientes/química , Feminino , Humanos , Técnicas In Vitro , Metacrilatos/química , Microscopia Confocal , Nortriptilina/administração & dosagem , Nortriptilina/toxicidade , Permeabilidade , Fatores de Tempo
6.
Ars pharm ; 50(2): 90-98, abr.-jun. 2009.
Artigo em Espanhol | IBECS | ID: ibc-73681

RESUMO

Este trabajo estudia los diferentes modelos de baremación para la adjudicación de oficinas defarmacias en las distintas comunidades autónomas. El objetivo final es analizar el perfil deladjudicatario que se propicia con ellos. De forma general, el concurso contempla el ejercicioprofesional como farmacéutico, la formación de pregrado y la formación posgrado, condistintos matices y pesos. En algunas autonomías se valoran, asimismo, los idiomascooficiales, una prueba escrita voluntaria sobre conocimientos y determinadas situacionesespeciales (minusvalía y paro).En general se propicia un perfil de adjudicatario que suma la experiencia laboral con unacontinua formación y reciclaje(AU)


This article studies the differences between the models of candidate classification for the adjudication of new pharmacies in the different Spanish self-governing regions. The objective of this study is to analyze the profile of the selected professional. Generally, the ranking takes into account the professional activity as pharmacist, the pre-graduate formation as well as the postgraduate, with different weights. Some of the 15 autonomies include as merits the cooficial languages, an optional written test and special situations as unemployment. In general, the criteria try to find out the best profile of pharmacist based on the professional experience and the postgraduate formation(AU)


Assuntos
Farmácias/provisão & distribuição , Descrição de Cargo , Papel Profissional , Assistência Farmacêutica/normas
7.
Eur J Pharm Biopharm ; 69(2): 588-96, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18191555

RESUMO

The influence of propylen glycol (PG), ethanol, and oleic acid (OA) on nortriptyline hydrochloride (NTH) penetration through human epidermis was studied in vitro at two different pH values (5.5 and 7.4). The influence of lactic acid and polysorbate 80 was studied for a pH of 5.5. Permeation studies through Heat Separated Epidermis, as well as the enhancing effect of the different vehicles, showed a pH dependency. A pH value of 5.5 in the donor solution decreases significantly the permeability coefficient (Kp) with respect to a pH value of 7.4 (0.011+/-0.004 x 10(-6) versus 0.36+/-0.04 x 10(-6)cm/s). The vehicles showed an increasing enhancement effect in the order: polysorbate 80>ethanol/PG/OA>PG>ethanol>ethanol/lactic acid>lactic acid at pH 5.5 while they reduced the permeation of NTH at pH 7.4. Considering the results obtained at pH 5.5, the maximum enhancement ratios were found for polysorbate 80 and the combination ethanol/PG/OA (10.72 and 3.90). Both vehicles were selected for designing a NTH transdermal delivery system (NTH-TDS) using (hydroxypropyl)methyl-cellulose as polymer. The NTH-TDS based on the combination of ethanol/PG/OA showed an enhancement ratio with respect to control of 2.09 and the addition of polysorbate 80 to the matrix, of 5.82.


Assuntos
Antidepressivos Tricíclicos/farmacocinética , Nortriptilina/farmacocinética , Absorção Cutânea/fisiologia , Administração Cutânea , Algoritmos , Antidepressivos Tricíclicos/administração & dosagem , Soluções Tampão , Fenômenos Químicos , Química Farmacêutica , Físico-Química , Cromatografia Líquida de Alta Pressão , Cultura em Câmaras de Difusão , Humanos , Concentração de Íons de Hidrogênio , Derivados da Hipromelose , Técnicas In Vitro , Lipídeos/química , Metilcelulose/análogos & derivados , Nortriptilina/administração & dosagem , Solubilidade , Solventes , Termodinâmica
8.
Cienc. tecnol. pharm ; 17(1): 35-38, ene. 2007.
Artigo em Es | IBECS | ID: ibc-056143

RESUMO

El presente artículo describe la regulación del peculiar concurso de traslados de oficinas de farmacia en la Comunidad Autónoma de Canarias. Se comenta asimismo el concurso de aperturas, por su conexión con el anterior. Se investigan las razones justificativas de la normativa canaria y, se comparan las alternativas similares de otras comunidades, como el baremo para el concurso de aperturas de la Comunidad Valenciana. Finalmente se enumeran los principales inconvenientes de este sistema


The present paper describes in detail the peculiar move procedure of the chemist shops that takes place in the Canary Island. It can be performed in any place of the Community. The paper also comments the procedure for new establishment installation, as it is clearly related. The reasons justifying the regulation are investigated and some other possibilities used by different autonomic governments are compared, as the merit scale used by the Valenciana Community. The disadvantages of the move procedure are also pointed out


Assuntos
Humanos , Serviço de Farmácia Hospitalar/organização & administração , Serviço de Farmácia Hospitalar/normas , Legislação como Assunto
9.
Ars pharm ; 48(4): 329-341, 2007.
Artigo em Es | IBECS | ID: ibc-64396

RESUMO

Actualmente en el Estado español se están produciendo problemas en el suministro de medicamentos a los serviciosfarmacéuticos. En el presente artículo se revisa la normativa vigente acerca de la distribución de medicamentos.Se comentan además las posibles causas del problema. También se analizan los medios que desarrolla el Estadopara evitar esta problemática y la postura de la Comunidad Valenciana que, de manera pionera, quiere regular enmateria de distribución farmacéutica, mediante una normativa con rango de Ley, para evitar los problemas quese suscitan


In this paper, we discuss the problems arising from the current supply problems of medicines to pharmacy outlets inSpain, as well as a revision of present regulations governing their distribution. In addition to the possible causes, ananalysis of the measures developed by the state to combat these problems has been made, as well as an assessment ofthe impact of new pioneering legislation passed by the regional government of Valencia, aimed at finding a solution


Assuntos
Preparações Farmacêuticas/provisão & distribuição , Legislação de Medicamentos/organização & administração , Licenciamento em Farmácia/legislação & jurisprudência , Farmácia/organização & administração , Serviço de Farmácia Hospitalar/provisão & distribuição , Legislação de Medicamentos/normas , Legislação de Medicamentos , Sistemas de Informação em Farmácia Clínica/legislação & jurisprudência , Sistemas de Informação em Farmácia Clínica/organização & administração , Sistemas de Informação em Farmácia Clínica/provisão & distribuição , Tecnologia Farmacêutica/organização & administração , Comitê de Farmácia e Terapêutica/legislação & jurisprudência , Formulário de Hospital/normas
10.
J Pharm Sci ; 95(8): 1733-41, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16795017

RESUMO

Labetalol is a widely used drug for the management of hypertension, which is preferably administered by the oral route despite its low bioavailability. The objective of this study is to ascertain the mechanisms underlying its absorption as an approach to help in predicting the influence of dosage changes, possible drug-drug and drug-fruit juice interactions. Perfusion experiments have been performed in rats in two sites of absorption: the intestine and the colon. The nonlinearity of the process has been established by means of the assay of a wide range of concentrations (2-2000 microM). Fitting of the concentration versus time data allows the estimation of passive diffusion constant in the intestine (1.42 +/- 0.05/h) and the colon (1.13 +/- 0.06/h), V(m) and K(m) of the input process (9.85 +/- 4.98 microM/h, and 10.44 +/- 26.16 microM, respectively) and K(m) of an efflux system (0.53 +/- 1.16 microM) and V(m) in both intestinal segments (2.60 +/- 11.37 microM . /h in the intestine and 0.66 +/- 1.38 microM . /h in the colon). The efflux carrier implicated is identified by means of several inhibition experiments, whose inhibition ability is mathematically estimated. Results suggest the p-glycoprotein as responsible for the efflux of labetalol.


Assuntos
Colo/metabolismo , Absorção Intestinal/fisiologia , Intestino Delgado/metabolismo , Labetalol/farmacocinética , Animais , Colo/efeitos dos fármacos , Absorção Intestinal/efeitos dos fármacos , Intestino Delgado/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar
11.
Cienc. tecnol. pharm ; 16(2): 73-77, abr. 2006. tab
Artigo em Es | IBECS | ID: ibc-050029

RESUMO

En la Ley 16/1997, de 25 de abril, de Regulación de Servicios de las Oficinas de Farmacia, se establece el derecho de transmisión de dichas oficinas a favor únicamente de farmacéuticos. Por otra parte, la normativa define el derecho de continuidad que se erige como la única excepción prevista reglamentariamente a este precepto. Este derecho de continuidad puede contemplar también el concepto de reserva de titularidad que puede considerarse como una especificidad dentro del mismo. Se hace un breve resumen de los orígenes de este precepto y se analiza la situación actual, que presenta una amplia variabilidad debido a las discrepancias de la normativa autonómica en materia de ordenación farmacéutica


Community pharmacies can only be owned by pharmacists, as enforced in the Law 16/1997, 25th April (Regulation of Community Pharmacy Services). Nevertheless, the continuity right allows a unique exception, which can also comprise the titular reservation (a special situation). A concise summary of the origin and development of this rule is presented. The situation in Spain nowadays is characterized as highly variable mainly due to the fact that autonomic governments are responsible for the pharmacy ordinance


Assuntos
Propriedade/legislação & jurisprudência , Serviços Comunitários de Farmácia/legislação & jurisprudência , Licenciamento em Farmácia/legislação & jurisprudência , Farmácia/organização & administração , Farmácia/normas , Química Farmacêutica/legislação & jurisprudência , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Indústria Farmacêutica/legislação & jurisprudência , Legislação Farmacêutica/normas , Propriedade/ética , Propriedade/organização & administração , Propriedade/normas , Propriedade/tendências
12.
Int J Pharm ; 307(1): 33-41, 2006 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-16257153

RESUMO

The efflux process due to p-glycoprotein-like mechanisms of ciprofloxacin (CIP) and grepafloxacin (GRX) has been studied "in situ" in rats and "in vitro" in Caco-2 cells. The results were modelled by a curve fitting procedure which allowed the characterization of the passive (Pd) and carrier mediated parameters (Vm and Km) from the raw data without initial velocities estimation. CIP absorption in rat was characterized as a passive diffusion at the assayed concentrations. Although the involvement of an efflux transporter cannot be ruled out, its relevance in the transport of the fluoroquinolone is negligible. In GRX absorption, an efflux process is implicated and it is detected in both absorption models. GRX permeability depends on the intestinal segment, reflecting the previously reported different expression level of the efflux transporters along the gut in rat. A first attempt to correlate the "in vitro" and the "in situ" data has been done. The mathematical model has been constructed using very simplistic assumptions and it will require further refinement but, nevertheless, the results are promising and demonstrate that a good modelling approach helps to identify the system critical parameters and how the system behaviour change when the parameters are modified as it happens when we move from the "in vitro" to the "in situ" level. Predicted versus experimental permeability values show a good correlation, demonstrating that the relevance of the secretion process "in situ" in rat can be predicted from the "in vitro" cell results.


Assuntos
Anti-Infecciosos/farmacocinética , Ciprofloxacina/farmacocinética , Fluoroquinolonas/farmacocinética , Absorção Intestinal , Intestino Delgado/metabolismo , Modelos Biológicos , Piperazinas/farmacocinética , Animais , Células CACO-2 , Permeabilidade da Membrana Celular , Difusão , Humanos , Masculino , Perfusão/métodos , Ratos , Ratos Wistar
13.
Cienc. tecnol. pharm ; 15(4): 183-187, oct.-dic. 2005.
Artigo em Es | IBECS | ID: ibc-041712

RESUMO

Se revisa la normativa relativa a la propiedadde las farmacias respecto a la disposición deque únicamente puede ostentar la propiedadde una farmacia (Reales Ordenanzas -derogadas-,leyes autonómicas de ordenación farmacéutica).Se alude asimismo a la normativa que contemplalos procedimientos de autorización (Ordende 21 de noviembre de 1979 y Orden de17 de enero de 1980 del Ministerio de Sanidady Seguridad Social) que representaron una garantíadel cumplimiento de este requisito. Secomentan algunas sentencias que ponen demanifiesto la problemática que ha surgido endeterminados momentos


The ruIes applying to the owners of the Spanishpharmacy establishments that restrict thepossibility to one establishment are reviewed.The procedures to obtain an authorization(Order of 21st November 1979 and Order of17th January 1980 from the Social Insuranceand Health Ministry) are also cited as theyconstituted a guarantee of requirement accomplishment.Some sentences considering illegalsituations are commented in order to point outthe importance of the rules


Assuntos
Licenciamento em Farmácia/legislação & jurisprudência , Licenciamento em Farmácia/normas , Legislação Farmacêutica/normas , Farmácias/legislação & jurisprudência , Farmácias/normas
14.
J Pharm Sci ; 94(5): 1039-47, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15793815

RESUMO

The mechanism underlying propylene glycol (PG) effects on acyclovir (ACV) penetration through human epidermis were studied. Solvent systems and Carbopol gels containing increasing percentage of PG (from 0% to 70%, w/w) were used. Viscosity studies of both vehicles were carried out to characterise the influence of rheological behaviour. In solvent systems skin permeation values of ACV increase as the concentration of PG increase yielding a maximum enhancement ratio (ER = 10) for 70% PG. The release rate of ACV from gels was determined. Higuchi's model was used to estimate the apparent diffusion coefficient of the drug. These values show a decrease as the content of PG in the vehicle increases; this effect could be attributed to the increase of the viscosity in the diffusional pathway. When gels are used skin permeation values of ACV were smaller than those of the solvent systems. This could be attributed to the network structure created by the polymer that increases the length of the diffusional pathway. The maximum ER (= 6.8) was for Carbopol gel containing 50% PG. Therefore, these gels can be considered candidates for further research to confirm their usefulness as delivery systems for ACV topical formulations.


Assuntos
Aciclovir/farmacocinética , Antivirais/farmacocinética , Propilenoglicóis/química , Absorção Cutânea/efeitos dos fármacos , Resinas Acrílicas , Aciclovir/administração & dosagem , Adulto , Algoritmos , Antivirais/administração & dosagem , Excipientes , Feminino , Humanos , Hidrogéis , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Pessoa de Meia-Idade , Polivinil , Solubilidade , Solventes , Termodinâmica , Viscosidade
15.
Xenobiotica ; 35(12): 1067-88, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16418062

RESUMO

The purpose was to develop a general mathematical model for estimating passive permeability and efflux transport parameters from in vitro cell culture experiments. The procedure is applicable for linear and non-linear transport of drug with time, <10 or >10% of drug transport, negligible or relevant back flow, and would allow the adequate correction in the case of relevant mass balance problems. A compartmental kinetic approach was used and the transport barriers were described quantitatively in terms of apical and basolateral clearances. The method can be applied when sink conditions are not achieved and it allows the evaluation of the location of the transporter and its binding site. In this work it was possible to demonstrate, from a functional point of view, the higher efflux capacity of the TC7 clone and to identify the apical membrane as the main resistance for the xenobiotic transport. This methodology can be extremely useful as a complementary tool for molecular biology approaches in order to establish meaningful hypotheses about transport mechanisms.


Assuntos
Transporte Biológico , Fluoroquinolonas/metabolismo , Modelos Teóricos , Sítios de Ligação , Células CACO-2 , Permeabilidade da Membrana Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Cinética , Proteínas de Membrana Transportadoras/metabolismo , Especificidade por Substrato , Fatores de Tempo , Verapamil/metabolismo , Verapamil/farmacologia
16.
Cienc. tecnol. pharm ; 14(2): 77-79, abr. 2004.
Artigo em Es | IBECS | ID: ibc-33349

RESUMO

El artículo revisa la definición de formulación magistral y enuncia la normativa que le es de aplicación. Resume su actual función en relación al pasado. Comenta la oportunidad que genera la normativa, centrada en la mejora del servicio que oferta. También analiza la amenaza que puede derivarse para la profesión de la génesis de categorías entre las oficinas y de un coste social y económico muy elevado en relación al volumen de la formulación sobre la dispensación total (AU)


Assuntos
Humanos , Legislação de Medicamentos , Química Farmacêutica/legislação & jurisprudência , Química Farmacêutica/normas , Qualidade dos Medicamentos Homeopáticos
18.
J Drug Target ; 11(4): 215-23, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-14578108

RESUMO

The aim of this work was to study the intestinal absorption process of triamterene in situ in rats in order to gain insight on its absorption mechanism. The study shows an example of application of a pharmacokinetic model for drug disappearance from a compartment by simultaneous first order and Michaelis-Menten processes to the intestinal drug disappearance by absorption in a non-steady state system. The parameter used to quantify absorption was the absorption rate constant, determined in situ by means of a loop perfusion technique, performed in colon and in whole small intestine of rat at three pHs (5.00, 7.00 and 8.00) and in the presence of folic acid and methotrexate. Different concentrations of the drug were perfused in each condition. The concentrations versus time data were modeled with different kinetic absorption and inhibition differential equations to obtain the passive and active transport components and to elucidate the inhibition mechanisms. The results obtained confirm that triamterene is absorbed by means of passive diffusion and by a transporter or transporters related to folates. Folic acid and methotrexate are able to inhibit triamterene absorption. The results do not allow the selection of a competitive or non-competitive model for inhibition and this fact could be due to the presence of different carriers. The possibility of the existence of a secretion process sensitive to verapamil is also discussed.


Assuntos
Ácido Fólico/farmacocinética , Absorção Intestinal/fisiologia , Metotrexato/farmacocinética , Modelos Biológicos , Triantereno/farmacocinética , Animais , Ácido Fólico/química , Masculino , Metotrexato/química , Ratos , Ratos Wistar , Triantereno/química
19.
Eur J Pharm Biopharm ; 55(2): 241-6, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12637104

RESUMO

The influence of the secretion process on the absorption of ciprofloxacin, grepafloxacin and sparfloxacin has been evaluated by means of inhibition studies. Two well known P-glycoprotein inhibitors (cyclosporine, verapamil), a mixed inhibitor of P-glycoprotein and the organic cation transporter OCT1 (quinidine) and a well established MRP substrate (p-aminohipuric acid) have been selected in order to distinguish the possible carriers implicated. An in situ rat gut perfusion model and CACO-2 permeability studies are used. Both methods suggest the involvement of several types of efflux transporters for every fluoroquinolone. The relevance of the secretory pathway depends on the intrinsic permeability of the quinolone. The in vitro model seems to be more suitable for discriminating mechanisms underlying the absorption process, while in situ studies are less sensitive to inhibition studies.


Assuntos
Anti-Infecciosos/farmacocinética , Ciprofloxacina/farmacocinética , Fluoroquinolonas/farmacocinética , Absorção Intestinal , Piperazinas/farmacocinética , Animais , Disponibilidade Biológica , Células CACO-2 , Cromatografia Líquida de Alta Pressão , Portadores de Fármacos , Humanos , Técnicas In Vitro , Masculino , Modelos Biológicos , Ratos , Ratos Wistar
20.
Rev. esp. quimioter ; 15(4): 313-324, dic. 2002.
Artigo em Es | IBECS | ID: ibc-18743

RESUMO

Streptococcus pneumoniae se considera el principal agente causal de la neumonía adquirida en la comunidad, además de estar implicado con frecuencia en exacerbaciones de bronquitis crónica, otitis media aguda, sinusitis, meningitis y otras infecciones. Durante los últimos años, en búsqueda de nuevas sustancias debido a la aparición de resistencias en este microorganismo, se han estudiado, entre otros agentes antibacterianos, las fluoroquinolonas. Asimismo, la biología molecular ha ayudado a estudiar y comprender casi todos los mecanismos bioquímicos de resistencia y las rutas para la diseminación de la información genética entre las bacterias. En esta revisión se repasa el mecanismo de acción de las quinolonas y los mecanismos causantes de la resistencia de S. pneumoniae a ellas, por su importancia clínica y epidemiológica. S. pneumoniae es un caso peculiar, puesto que en este microorganismo la actividad bactericida puede producirse a través de la girasa, la topoisomerasa IV o ambas, dependiendo de la estructura de la quinolona, lo cual implica una influencia de la estructura en el logro del éxito antimicrobiano. Es importante, pues, conocer el prototipo de resistencia para hacer una recomendación de la antibioticoterapia adecuada, cuando esté indicada. (AU)


Assuntos
Relação Estrutura-Atividade , Streptococcus pneumoniae , Farmacorresistência Bacteriana , Anti-Infecciosos , Parede Celular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...